Home/ Stocks/ NDRA

ENDRA Life Sciences Inc. Common Stock

NDRA XNAS

$3.46 -0.02 (-0.57%) ▼ 15-min delayed

Open

$3.40

High

$3.52

Low

$3.31

Volume

5.2K

Market Cap

$4.06M

About ENDRA Life Sciences Inc. Common Stock

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Sector: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS Employees: 16 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-1,595,959	$-2.10
Q2 2025	$0	$-1,225,912	N/A
Q1 2025	$0	$-1,036,330	N/A
FY 2024	$0	$-11,507,947	N/A

Earnings & Analyst Ratings

Next Earnings: Wed, May 13, 2026

Calendar →

TickerDaily Coverage

Why Is ENDRA Life Sciences Inc. Common Stock (NDRA) Stock Up 49.1% Today?

Market News David Brooks · Feb 26, 2026

ENDRA Life Sciences Inc. (NDRA) stock exploded higher by 49.1%, closing at $5.68 after trading as...

View All Coverage →

Get NDRA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on ENDRA Life Sciences Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.